B.C. biotech company AbCellera Biologics goes public, shares surge 170% on Nasdaq

📆 12/11/2020 4:15 PM
📰 VancouverSun

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 61%

United States News News

United States United States Latest News,United States United States Headlines

AbCellera says the IPO will raise US$483 million for its business, which analyzes the immune system to help drug developers treat diseases.

The company’s top investors include board member Peter Thiel, a co-founder of PayPal and early investor in Facebook.

AbCellera announced last month it was working with Eli Lilly to develop a treatment for COVID-19, and that its Phase 2 clinical data had received interim authorization by Health Canada.Share this article in your social network

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

United States United States Latest News, United States United States Headlines